::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

AN ASSESSMENT OF HEPATITIS C INFECTION IN TYPE-II DIABETICS

AUTHORS:

Dr Ayesha Qazi, Dr. Syeda Tooba Mehdi, Dr. Zahra Imran

ABSTRACT:

Objective: To assess hepatitis C infection in type-II diabetics presenting at DHQ Hospital Bhakkar Material and methods: This cross sectional study was conducted DHQ Hospital Bhakkar from July 2019 to December 2019 over the period of 6 months. Total 200 patients with type-II DM were selected for the study and hepatitis C was assessed in selected patients. Results: Mean age of the patients was 50.79 ± 12.21 years and frequency of hepatitis C was 70 [35%]. Male patients were 82 [41%] and female patients were 118 [59%]. Hepatitis C infection was insignificantly [P = 0.7635] associated with gender, DM status [controlled or poorly controlled] and duration of DM, but dyslipidemia was significantly associated with the hepatitis C infection. Conclusion: Results of this study revealed that a hepatitis C infection was most frequently prevalent in type-II diabetics. Male and female can equally be victim of hepatitis C infection. Results of this study also revealed that there is no associate of hepatitis C infection with good controlled DM or poorly controlled DM. Interestingly we found that dyslipidemia was significantly associated frequency of hepatitis C infection.